USANA Health Sciences Reports Fiscal Year and Fourth Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
USANA Health Sciences (USNA) Misses Q4 EPS by 25c
February 8, 2022 4:18 PM ESTUSANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.03, $0.25 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $267 million versus the consensus estimate of $271.93 million.
GUIDANCE:
USANA Health Sciences sees FY2022 EPS of $5.25-$6.00, versus the... More
